Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin

Oral anticoagulation therapy is standard of care for patients with nonvalvular atrial fibrillation to prevent stroke. This study compared rivaroxaban and warfarin for stroke and all-cause mortality risk reduction in a real-world setting. METHODS—: This retrospective cohort study (2011–2017) included...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Mark, Chen, Yen-Wen, Lin, Jennifer H., Kogan, Emily, Twyman, Kathryn, Milentijevic, Dejan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004448/
https://www.ncbi.nlm.nih.gov/pubmed/31888412
http://dx.doi.org/10.1161/STROKEAHA.119.025554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004448/
https://www.ncbi.nlm.nih.gov/pubmed/31888412
http://dx.doi.org/10.1161/STROKEAHA.119.025554

Ejemplares similares